Regnante Keith

Keros Therapeutics, Inc. · CHIEF FINANCIAL OFFICER

Regnante Keith is listed in filings as CHIEF FINANCIAL OFFICER at Keros Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 26, 2026, including sale activity. Recent filings connect the profile to Keros Therapeutics, Inc. (KROS). The current snapshot covers public activity from Feb 19, 2025 to Feb 26, 2026. Reported amounts are shown as $77.5K to $931.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.